Welcome to our dedicated page for Fidelity National Financial In SEC filings (Ticker: FNF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Fidelity National Financial’s dual world of title insurance and annuity products means wading through hundreds of pages that juggle escrow balances, statutory reserves, and real-estate cycle commentary. If finding claim loss ratios or spotting an executive’s Form 4 sale feels like searching needles in a haystack, you’re not alone.
Stock Titan solves that problem. Our AI dissects every Fidelity National Financial quarterly earnings report 10-Q filing and Fidelity National Financial annual report 10-K simplified version, surfacing the exact tables that show title premium margins, reserve development, and F&G spread income. Need breaking news? We post Fidelity National Financial Form 4 insider transactions real-time alongside concise notes on context and trend. Even 8-K event language—rate-lock volume updates, unexpected M&A, or dividend changes—arrives here with Fidelity National Financial 8-K material events explained in plain English.
- AI-powered summaries translate actuarial jargon, turning dense disclosures into clear bullet points—ideal for understanding Fidelity National Financial SEC documents with AI.
- Real-time alerts for Fidelity National Financial executive stock transactions Form 4 and director purchases.
- Comprehensive coverage of every filing type, from the proxy statement that details Fidelity National Financial proxy statement executive compensation to shelf registrations for debt and preferred stock.
- Practical use cases: compare quarter-over-quarter title order counts, monitor annuity surrender trends, or run a Fidelity National Financial earnings report filing analysis without manual page flipping.
Whether you’re searching “Fidelity National Financial insider trading Form 4 transactions” or “Fidelity National Financial SEC filings explained simply,” this page delivers authoritative data, instant context, and the clarity you need to act decisively.
Fidelity National Financial (FNF) reported an insider equity award on a Form 4. A director acquired 4,870 shares of common stock on 11/10/2025 at a stated price of $0, reflecting a grant of restricted common stock. Following this transaction, the reporting person beneficially owned 235,439 shares, held directly.
The grant vests in three equal annual installments beginning on November 10, 2026. The filing was made by one reporting person and reflects a routine equity compensation award.
Fidelity National Financial (FNF) reported a director’s acquisition of 4,870 shares of common stock on 11/10/2025. The filing notes this was a grant of restricted common stock at $0 per share, vesting in three equal annual installments beginning November 10, 2026.
Following the grant, the director beneficially owns 17,545 shares, held directly. This is a routine equity award aligning director compensation with shareholder interests through time-based vesting.
Fidelity National Financial (FNF) reported an insider equity award. A director acquired 4,870 shares of common stock on November 10, 2025 at $0, reflecting a grant of restricted stock.
The award vests in three equal annual installments beginning on November 10, 2026. Following the grant, the director directly owns 41,620 shares of FNF common stock.
Fidelity National Financial (FNF) disclosed an insider equity award. A director acquired 4,870 shares of common stock on 11/10/2025 at $0 as a grant of restricted stock, which vests in three equal annual installments beginning on November 10, 2026.
Following this grant, the director beneficially owns 282,675 shares, reported as directly held.
Fidelity National Financial (FNF) reported an insider equity award. A company director received a grant of 4,870 shares of restricted common stock on November 10, 2025, at a stated price of $0.
The award vests in three equal annual installments beginning on November 10, 2026. Following this transaction, the reporting person beneficially owned 349,511.6 shares, held directly.
Fidelity National Financial (FNF) reported a director equity grant. On 11/10/2025, the director received 4,870 shares of common stock at $0 as restricted stock, vesting in three equal annual installments beginning on 11/10/2026. Following the grant, the director beneficially owned 19,186 shares, held directly. This reflects routine equity compensation disclosed on a Form 4.
Fidelity National Financial (FNF) reported an insider equity grant. A director acquired 4,870 shares of common stock on 11/10/2025 as a restricted stock award priced at $0. Following the transaction, the director beneficially owns 149,340.553 shares, held directly.
The award vests in three equal annual installments beginning on November 10, 2026.
Fidelity National Financial (FNF)acquired 29,218 shares of restricted common stock at $0. The award vests in three equal annual installments beginning 11/10/2026, subject to performance criteria in the award agreement.
Following the grant, directly held common stock was 195,026.988 shares. Indirect holdings included 2,606.07 shares in a 401(k) account, 473 shares in an IRA, and 74,898 shares in a trust.
Fidelity National Financial (FNF) reported an insider equity grant on a Form 4. The reporting person, a Director and Executive Vice‑Chairman, acquired 55,653 shares of restricted common stock on 11/10/2025 at $0 under transaction code A.
The award vests in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement. Following the transaction, beneficial holdings were 200,387.2675 shares direct, plus 565.2 indirect via a 401(k) account and 2,150,955 indirect via the Quirk 2002 Trust.
Fidelity National Financial (FNF) reported an insider equity grant by its EVP & Chief Financial Officer. On 11/10/2025, the officer acquired 31,044 shares of common stock at $0, reflecting a grant of restricted stock. These shares vest in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement.
Following the transaction, beneficial ownership stands at 140,327.3516 shares direct, plus indirect holdings of 272,759 shares via the Park Family Trust and 3.11 shares in a 401(k) account.